Cross‐regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens
Open Access
- 22 September 2008
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 218 (2) , 246-250
- https://doi.org/10.1002/jcp.21597
Abstract
Natural killer T (NKT) cells generally recognize lipid‐antigens presented in the context of the MHC class I‐like molecule CD1d. CD1d‐restricted NKT cells consist of two broad subsets: Type I, which express an invariant T cell receptor (TCR) and type II, which utilize diverse TCR gene segments. A major type II NKT subset has been shown to recognize a self‐glycolipid, sulfatide. Both subsets play important roles in autoimmune diseases, tumor surveillance, and infectious diseases. While type I NKT cells protect from tumor growth by enhancing tumor surveillance, type II NKT cells may suppress anti‐tumor immune responses. In a murine autoimmune hepatitis model, type I NKT cells contribute to pathogenesis, whereas activation of sulfatide‐reactive type II NKT cells protects from disease. Sulfatide‐mediated activation of type II NKT cells results in modification of dendritic cells and induction of anergy in type I NKT cells. Elucidation of this novel pathway of cross‐regulation among NKT cell subsets will provide tools for intervention in autoimmune diseases and for designing strategies for effective anti‐tumor immunity. J. Cell. Physiol. 218: 246–250, 2009.Keywords
This publication has 84 references indexed in Scilit:
- Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancerBlood, 2008
- Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphomaBlood, 2008
- Natural killer T cells exacerbate liver injury in a transforming growth factor β receptor II dominant-negative mouse model of primary biliary cirrhosisHepatology, 2008
- Innate Vα14+ natural killer T cells mature dendritic cells, leading to strong adaptive immunityImmunological Reviews, 2007
- Type II NKT cell–mediated anergy induction in type I NKT cells prevents inflammatory liver diseaseJournal of Clinical Investigation, 2007
- Invariant and Noninvariant Natural Killer T Cells Exert Opposite Regulatory Functions on the Immune Response during Murine SchistosomiasisInfection and Immunity, 2007
- A Phase I Study ofIn vitroExpanded Natural Killer T Cells in Patients with Advanced and Recurrent Non–Small Cell Lung CancerClinical Cancer Research, 2006
- Therapeutic Effect of Repeated Natural Killer T Cell Stimulation in Mouse Cholangitis Complicated by ColitisDigestive Diseases and Sciences, 2005
- Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patientsThe Journal of Experimental Medicine, 2005
- Early quantitative and functional deficiency of NK1+‐like thymocytes in the NOD mouseEuropean Journal of Immunology, 1996